Plain-English translation of NCT07258186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are asking people with endometrial cancer to donate tumor tissue and blood samples during their surgical procedure. The team will grow these cancer cells in the laboratory (a process called creating "organoids") and use them to test how the cancer might respond to different treatments, including immunotherapy drugs that help the immune system fight cancer.
Every patient's cancer is unique, and what works for one person may not work for another. By growing cancer cells from individual patients in the lab, doctors hope to find ways to predict which treatments will work best for each person before starting therapy.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have a blood sample taken before your scheduled surgery. During your surgery, the surgical team will collect a small piece of your tumor tissue and surrounding normal tissue. These samples will be frozen and sent to the research laboratory, where scientists will grow your cancer cells in dishes and test how they respond to different treatments. You will not need additional visits or appointments beyond your standard cancer care.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Italy
Sponsor
Regina Elena Cancer Institute
Collaborators
Azienda Ospedaliera Universitaria Integrata Verona
Enrollment target
~20 participants
Started
March 2025
Primary completion
September 2028
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Giovanni Blandino, Medical Doctor
Regina Elena Cancer Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.